抗体药物研发现状与发展态势

被引：1

作者：

于建荣

陈大明

江洪波

机构：

[1] 中国科学院上海生命科学信息中心

来源：

生物产业技术 | 2009年 / 01期

关键词：

抗体药物; 发展态势; 单抗; 特异性; 抗体库; 人源化; 多克隆抗体;

D O I：

暂无

中图分类号：

R945 [生物药剂学];

学科分类号：

100602 ; 100702 ;

摘要：

<正>抗体药物是以细胞工程技术和基因工程技术为主体的抗体工程技术制备的药物,具有特异性高、性质均一、可针对特定靶点定向制备等优点,在各种疾病治疗,特别是肿瘤治疗领域的应用前景备受关注。当前,抗体药物的研究与开发已成为生物技术药物领域研究的热点,居近年来所有医药生物技术产品之首。从分子构成来看,抗体药物可分为三类:①抗体或抗体片段,完整的抗体

引用

页码：49 / 53

页数：5

共 7 条

[1] The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies [J].

Birtalan, Sara ;

Zhang, Yingnan ;

Fellouse, Frederic A. ;

Shao, Lihua ;

Schaefer, Gabriele ;

Sidhu, Sachdev S. .

JOURNAL OF MOLECULAR BIOLOGY, 2008, 377 (05) :1518-1528

[2] High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries [J].

Fellouse, Frederic A. ;

Esaki, Kaori ;

Birtalan, Sara ;

Raptis, Demetrios ;

Cancasci, Vincenzo J. ;

Koide, Akiko ;

Jhurani, Parkash ;

Vasser, Mark ;

Wiesmann, Christian ;

Kossiakoff, Anthony A. ;

Koide, Shohei ;

Sidhu, Sachdev S. .

JOURNAL OF MOLECULAR BIOLOGY, 2007, 373 (04) :924-940

[3]

Recombinant polyclonal antibodies: the next generation of antibody therapeutics?.[J].John S. Haurum.Drug Discovery Today.2006, 13

[4] Recombinant polyclonal antibodies for cancer therapy [J].

Sharon, J ;

Liebman, MA ;

Williams, BR .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 96 (02) :305-313

[5] Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions [J].

Sidhu, SS ;

Li, B ;

Chen, Y ;

Fellouse, FA ;

Eigenbrot, C ;

Fuh, G .

JOURNAL OF MOLECULAR BIOLOGY, 2004, 338 (02) :299-310

[6]

High-throughput generation and engineering of recombinant human antibodies.[J]..Journal of Immunological Methods.2001, 1

[7]

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1 Edited by I. A. Wilson.[J]..Journal of Molecular Biology.2000, 1

← 1 →